참고문헌
- Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 2004;65:116-128. https://doi.org/10.1111/j.1523-1755.2004.00367.x
- Utimura R, Fujihara CK, Mattar AL, Malheiros DM, Noronha IL, Zatz R. Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 2003;63:209-216. https://doi.org/10.1046/j.1523-1755.2003.00736.x
- Ehrly AM. Improvement of the flow properties of blood: a new therapeutical approach in occlusive arterial disease. Angiology 1976;27:188-196. https://doi.org/10.1177/000331977602700306
- Badri S, Dashti-Khavidaki S, Lessan-Pezeshki M, Abdollahi M. A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria. J Pharm Pharm Sci 2011;14:128-137. https://doi.org/10.18433/J3BP4G
- Chen YM, Lin SL, Chiang WC, Wu KD, Tsai TJ. Pentoxifylline ameliorates proteinuria through suppression of renal monocyte chemoattractant protein-1 in patients with proteinuric primary glomerular diseases. Kidney Int 2006;69:1410-1415. https://doi.org/10.1038/sj.ki.5000302
- Sun HK, Lee YM, Han KH, Kim HS, Ahn SH, Han SY. Phosphodiesterase inhibitor improves renal tubulointerstitial hypoxia of the diabetic rat kidney. Korean J Intern Med 2012;27:163-170. https://doi.org/10.3904/kjim.2012.27.2.163
- Palm F, Friederich M, Carlsson PO, Hansell P, Teerlink T, Liss P. Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability. Am J Physiol Renal Physiol 2008;294:F30-F37. https://doi.org/10.1152/ajprenal.00166.2007
- dos Santos EA, Li LP, Ji L, Prasad PV. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging. Invest Radiol 2007;42:157-162. https://doi.org/10.1097/01.rli.0000252492.96709.36
- Han KH, Han SY, Kim HS, Kang YS, Cha DR. Prolonged administration enhances the renoprotective effect of pentoxifylline via anti-inflammatory activity in streptozotocininduced diabetic nephropathy. Inflammation 2010;33:137-143. https://doi.org/10.1007/s10753-009-9167-6
- McCormick BB, Sydor A, Akbari A, Fergusson D, Doucette S, Knoll G. The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis. Am J Kidney Dis 2008;52:454-463. https://doi.org/10.1053/j.ajkd.2008.01.025